Blood test could warn patients of looming heart failure after virus

NCT ID NCT06742008

Summary

This study aims to see if a simple blood test can predict which patients recovering from viral heart inflammation will develop a serious heart muscle disease called dilated cardiomyopathy. Researchers will follow 300 patients for up to 5 years, checking their blood for specific antibodies and tracking their heart health. The goal is to identify patients at highest risk early, so doctors can monitor them more closely and potentially intervene sooner.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VIRAL MYOCARDITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

    RECRUITING

    Wuhan, Hubei, 430000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.